We are live on
!
Find out more
SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 1 |
O
1
OrbiMed
New York
| $184M | – | – | – |
|
| 2 |
VC
2
Vivo Capital
Palo Alto,
California
| $38.2M | – | – | – |
|
| 3 |
NAH
3
Neumann Advisory (HK)
Central,
Hong Kong
| $2.04M | – | – | – |
|
| 4 |
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $106K | – | – | – |
|
| 5 |
5
Morgan Stanley
New York
| $59.2K | +$13 | +2 | +0% |
|
| 6 |
6
Wells Fargo
San Francisco,
California
| $29.6K | -$1.5K | -231 | -5% |
|
| 7 |
7
UBS Group
Zurich,
Switzerland
| $16K | +$1.62K | +250 | +11% |
|
| 8 |
HI
8
Harbour Investments
Madison,
Wisconsin
| $503 | -$32 | -5 | -6% |
|
| 9 |
HI
9
Horizon Investments
Charlotte,
North Carolina
| $336 | -$336 | -52 | -50% |
|